There are no gains like biotech gains, a fact Biora Therapueutics (BIOR) investors can happily attest to following this week’s market action. Shares of the micro-cap surged by over 200% after th...
There are no gains like biotech gains, a fact Biora Therapueutics (BIOR) investors can happily attest to following this week’s market action. Shares of the micro-cap surged by over 200% after th...